Susquehanna International Group, LLP Sc Pharmaceuticals Inc. Transaction History

Susquehanna International Group, LLP

$688 Billion
Q2 2025

A detailed history of Susquehanna International Group, LLP transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 138,460 shares of SCPH stock, worth $785,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,460

Previous 73,909 87.34%

Holding current value

$785,068

Previous $194,000 171.65%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.02 - $4.27 $130,393 - $275,632	64,551 Added 87.34%	138,460 $527,000
Q1 2025 May 14, 2025	BUY	$2.63 - $3.68 $138,451 - $193,726	52,643 Added 247.55%	73,909 $194,000
Q4 2024 Feb 14, 2025	BUY	$3.14 - $4.53 $7,850 - $11,325	2,500 Added 13.32%	21,266 $75,000
Q3 2024 Nov 14, 2024	SELL	$4.12 - $5.51 $21,296 - $28,481	-5,169 Reduced 21.6%	18,766 $85,000
Q2 2024 Aug 15, 2024	SELL	$3.51 - $5.21 $10,365 - $15,385	-2,953 Reduced 10.98%	23,935 $104,000
Q1 2024 May 07, 2024	SELL	$4.86 - $6.39 $183,848 - $241,727	-37,829 Reduced 58.45%	26,888 $134,000
Q4 2023 Feb 14, 2024	BUY	$4.7 - $6.63 $189,062 - $266,698	40,226 Added 164.25%	64,717 $405,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $9.82 $428,148 - $600,630	-61,164 Reduced 71.41%	24,491 $174,000
Q2 2023 Aug 11, 2023	SELL	$8.94 - $11.74 $1.26 Million - $1.66 Million	-140,998 Reduced 62.21%	85,655 $872,000
Q1 2023 May 16, 2023	BUY	$5.59 - $9.47 $757,143 - $1.28 Million	135,446 Added 148.5%	226,653 $2.06 Million
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $112,756 - $211,208	28,049 Added 44.41%	91,207 $653,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.52 $42,403 - $61,711	-9,465 Reduced 13.03%	63,158 $412,000
Q2 2022 Aug 15, 2022	BUY	$4.3 - $6.48 $137,316 - $206,932	31,934 Added 78.48%	72,623 $350,000
Q1 2022 May 16, 2022	BUY	$3.9 - $6.11 $158,687 - $248,609	40,689 New	40,689 $231,000
Q2 2020 Aug 14, 2020	SELL	$7.01 - $10.96 $82,430 - $128,878	-11,759 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.4 - $10.45 $63,498 - $122,881	11,759 New	11,759 $87,000
Q1 2019 May 15, 2019	SELL	$2.84 - $4.18 $50,299 - $74,031	-17,711 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.76 - $5.61 $66,593 - $99,358	17,711 New	17,711 $67,000

Others Institutions Holding SCPH

# of Institutions

101

Shares Held

36.5M

Call Options Held

757K

Put Options Held

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $155M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Sc Pharmaceuticals Inc. Transaction History